476 related articles for article (PubMed ID: 30703203)
1. Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration.
Dalvin LA; Starr MR; AbouChehade JE; Damento GM; Garcia M; Shah SM; Hodge DO; Meissner I; Bakri SJ; Iezzi R
JAMA Ophthalmol; 2019 May; 137(5):483-490. PubMed ID: 30703203
[TBL] [Abstract][Full Text] [Related]
2. Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.
Yashkin AP; Hahn P; Sloan FA
Ophthalmology; 2016 Oct; 123(10):2225-31. PubMed ID: 27523614
[TBL] [Abstract][Full Text] [Related]
3. Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis.
Hanhart J; Comaneshter DS; Freier-Dror Y; Vinker S
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):651-663. PubMed ID: 29429131
[TBL] [Abstract][Full Text] [Related]
4. Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration.
Etminan M; Maberley DA; Babiuk DW; Carleton BC
Am J Ophthalmol; 2016 Mar; 163():53-58. PubMed ID: 26701272
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-up of Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Kung FF; Starr MR; Bui YT; Mejia CA; Bakri SJ
Ophthalmol Retina; 2020 Nov; 4(11):1047-1053. PubMed ID: 32439455
[TBL] [Abstract][Full Text] [Related]
6. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Shah SM; Boopathiraj N; Starr MR; Dalvin LA; AbouChehade J; Damento G; Garcia MD; Hodge DO; Bakri SJ; Sit AJ; Iezzi R
Am J Ophthalmol; 2022 Nov; 243():98-108. PubMed ID: 35932820
[TBL] [Abstract][Full Text] [Related]
7. Incidence of myocardial infarction, stroke, and death in patients with age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor therapy.
Ng WY; Tan GS; Ong PG; Cheng CY; Cheung CY; Wong DW; Mathur R; Chow KY; Wong TY; Cheung GC
Am J Ophthalmol; 2015 Mar; 159(3):557-64.e1. PubMed ID: 25497143
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal anti-VEGF therapy is not associated with a higher risk of all-cause mortality in patients with macular oedema caused by posterior segment vascular diseases.
Loukovaara S; Haukka J
Acta Ophthalmol; 2021 Sep; 99(6):e893-e898. PubMed ID: 33389820
[TBL] [Abstract][Full Text] [Related]
9. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
[TBL] [Abstract][Full Text] [Related]
10. Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor.
Starr MR; Dalvin LA; AbouChehade JE; Damento GM; Garcia MD; Shah SM; Hodge DO; Meissner I; Iezzi R; Bakri SJ
Ophthalmic Surg Lasers Imaging Retina; 2019 May; 50(5):e140-e157. PubMed ID: 31100168
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between intravitreal anti-VEGF therapy and subretinal hemorrhage in patients with exudative age-related macular degeneration].
Kauffmann Y; Isaico R; Lefebvre A; Bron AM; Creuzot-Garcher C
J Fr Ophtalmol; 2014 Mar; 37(3):195-201. PubMed ID: 24534623
[TBL] [Abstract][Full Text] [Related]
12. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
[TBL] [Abstract][Full Text] [Related]
13. Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy.
Chen YY; Chou P; Huang YF; Chien HJ; Wu YC; Lee CC; Huang LY; Chen HH
BMC Ophthalmol; 2019 Dec; 19(1):268. PubMed ID: 31888553
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study.
Jeon HL; Byun SJ; Pratt NL; Sultana J; Park SJ; Shin JY
Br J Ophthalmol; 2021 Apr; 105(4):543-548. PubMed ID: 32522792
[TBL] [Abstract][Full Text] [Related]
15. Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration.
Kim M; Kim ES; Seo KH; Yu SY; Kwak HW
Indian J Ophthalmol; 2016 Jun; 64(6):427-33. PubMed ID: 27488150
[TBL] [Abstract][Full Text] [Related]
16. [Interest of optical coherence tomography performed immediately before intravitreal injection of anti-VEGF in exudative AMD].
Moyal L; Cohen SY; Pedinielli A; Semoun O; Lalloum F; Jung C; Souied E
J Fr Ophtalmol; 2015 Sep; 38(7):573-9. PubMed ID: 25997681
[TBL] [Abstract][Full Text] [Related]
17. Ten-year mortality and long-term visual acuity outcomes in patients with exudative age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor injections.
Young SL; Anderson MJ; Borooah S; Armbrecht AM; Cackett PD
Age Ageing; 2022 Jan; 51(1):. PubMed ID: 34977924
[TBL] [Abstract][Full Text] [Related]
18. SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration.
Enseleit F; Michels S; Sudano I; Stahel M; Zweifel S; Schlager O; Becker M; Winnik S; Nägele M; Flammer AJ; Neidhart M; Graf N; Matter CM; Seifert B; Lüscher TF; Ruschitzka F
Ophthalmologica; 2017; 238(4):205-216. PubMed ID: 28866675
[TBL] [Abstract][Full Text] [Related]
19. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration.
Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L
Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084
[TBL] [Abstract][Full Text] [Related]
20. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.
Munk MR; Ceklic L; Ebneter A; Huf W; Wolf S; Zinkernagel MS
Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
